Structures by: Lou B.
Total: 29
C16H18N8O7Zn2
C16H18N8O7Zn2
New Journal of Chemistry (2013) 37, 2 309
a=17.083(2)Å b=11.2862(9)Å c=11.2092(15)Å
α=90.00° β=106.755(7)° γ=90.00°
C21H20N8O7Zn2
C21H20N8O7Zn2
New Journal of Chemistry (2013) 37, 2 309
a=16.023(2)Å b=13.4229(16)Å c=11.4932(19)Å
α=90.00° β=103.331(9)° γ=90.00°
C13H11N5O4Zn
C13H11N5O4Zn
New Journal of Chemistry (2013) 37, 2 309
a=11.8565(11)Å b=11.0480(8)Å c=20.2252(16)Å
α=90.00° β=90.00° γ=90.00°
C12H9Cu3N6S3
C12H9Cu3N6S3
Chemical Communications (2004) 22 2578-2579
a=11.84(3)Å b=7.874(7)Å c=17.51(4)Å
α=90.00° β=90.00° γ=90.00°
2(C20H28Cu2N6O8),C10H8N2,8(H2O)
2(C20H28Cu2N6O8),C10H8N2,8(H2O)
CrystEngComm (2012) 14, 6 2040
a=11.202(10)Å b=12.897(11)Å c=28.51(2)Å
α=90.00° β=90.00° γ=90.00°
C20H28Cu2N6O8,8(H2O)
C20H28Cu2N6O8,8(H2O)
CrystEngComm (2012) 14, 6 2040
a=7.261Å b=10.749Å c=11.075Å
α=68.967(7)° β=77.087(8)° γ=76.293(8)°
Iridium bis(2-phenylpyridinato-N,C2) (4,4,5,5,5-pentafluoro-1- (1,10-phenanthrolin-2-yl)pentane-1,3-dionate)
C39H24F5IrN4O2
Dalton Transactions (2008) 41 5577
a=12.612(2)Å b=17.190(3)Å c=18.641(3)Å
α=90.00° β=98.554(3)° γ=90.00°
Bis(Iridium bis(2-phenylpyridinato-N,C2) (4,4,5,5,5- pentafluoro-1-(1,10-phenanthrolin-2-yl)pentane-1,3-dionate)) Neodymium nitrate
C87H65.50F10Ir2N13.50NdO14
Dalton Transactions (2008) 41 5577
a=15.4979(18)Å b=17.028(2)Å c=34.616(4)Å
α=90.00° β=90.743(7)° γ=90.00°
C39H26F4IrN5O2
C39H26F4IrN5O2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 43 11410-11418
a=11.4430(11)Å b=17.2090(17)Å c=17.9900(17)Å
α=90.543(4)° β=99.623(18)° γ=103.398(18)°
C39H25Cl2F5IrN5O2
C39H25Cl2F5IrN5O2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 43 11410-11418
a=12.5020(14)Å b=21.921(2)Å c=12.6430(15)Å
α=90.00° β=96.317(3)° γ=90.00°
C37H31F7IrN5O4
C37H31F7IrN5O4
Dalton transactions (Cambridge, England : 2003) (2011) 40, 43 11410-11418
a=16.912(2)Å b=22.958(3)Å c=19.037(2)Å
α=90.00° β=107.182(3)° γ=90.00°
Tetraaquabis(1,3-dimethyl-2,6-dioxo-3,7-dihydro-1<i>H</i>-purin-9-ido)magnesium(II)
2(C7H7N4O2)Mg,4(H2O)
Acta Crystallographica Section E (2015) 71, 3 321-323
a=7.694(4)Å b=13.399(7)Å c=9.739(5)Å
α=90.00° β=105.169(9)° γ=90.00°
(5<i>R</i>)-5-ethylamino-3-(3-methoxypropyl)-2,2-dioxo-2,9-dithia-3-azabicyclo[4.3.0]nona-1(6)7-diene-8-sulfonamide
C12H21N3O5S3
Acta Crystallographica Section E (2016) 72, 5 692-695
a=9.698(2)Å b=8.8127(19)Å c=10.133(2)Å
α=90.00° β=92.248(3)° γ=90.00°
7-Phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoate 1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium monohydrate
C4H12NO3,C22H25O4,H2O
Acta Crystallographica Section E (2014) 70, 10 228-230
a=23.506(9)Å b=9.665(4)Å c=11.344(5)Å
α=90.00° β=94.223(7)° γ=90.00°
1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium 2-(4-isobutylphenyl)propanoate
C4H12NO3,C13H17O2
Acta Crystallographica Section E (2015) 71, 8 923-925
a=17.523(7)Å b=10.400(4)Å c=9.976(4)Å
α=90° β=97.032(7)° γ=90°
1-Ethyl-6-fluoro-7-(4-formylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline- 3-carboxylic acid
C17H18FN3O4
Acta Crystallographica Section E (2007) 63, 11 o4281-o4281
a=8.6689(17)Å b=9.6727(19)Å c=10.142(2)Å
α=73.41(3)° β=81.41(3)° γ=86.48(3)°
4-(3-carboxy-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-quinolyl)piperazinium dihydrogen phosphate monohydrate
C16H19FN3O3,H2O4P,H2O
Acta Crystallographica Section C (2007) 63, 12 o731-o733
a=7.1918(14)Å b=8.9400(18)Å c=15.792(3)Å
α=103.81(3)° β=94.01(3)° γ=106.51(3)°
4-(3-carboxy-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-quinolyl)piperazinium dihydrogen phosphate monohydrate
C17H19FN3O3,H2O4P,H2O
Acta Crystallographica Section C (2007) 63, 12 o731-o733
a=7.2582(15)Å b=8.9979(18)Å c=15.712(3)Å
α=100.93(3)° β=96.00(3)° γ=105.74(3)°
{3-[4-(aminocarbonylmethyl)phenoxy]-2-hydroxypropyl)isopropylammonium 4-aminobenzoate monohydrate
C14H23N2O3,C7H6NO2,H2O
Acta Crystallographica Section C (2007) 63, 12 o714-o716
a=28.547(6)Å b=7.4223(15)Å c=23.822(5)Å
α=90.00° β=122.34(3)° γ=90.00°
Poly[{μ~3~-3-[4-(1<i>H</i>-imidazol-1-ylmethyl)phenyl]prop-2-enoato- κ<i>N</i>:η^2^:κ<i>O</i>}copper(I)]
C13H11CuN2O2
Acta Crystallographica Section E (2011) 67, 5 m640
a=9.7894(19)Å b=9.7894(19)Å c=10.483(2)Å
α=90.00° β=90.00° γ=120.00°
C29H30Cl2CoN4O3S4
C29H30Cl2CoN4O3S4
Inorganic Chemistry (2005) 44, 9175-9184
a=18.457(6)Å b=16.262(5)Å c=21.388(6)Å
α=90.00° β=90.00° γ=90.00°
C19H26Cl2CoN4O3S2
C19H26Cl2CoN4O3S2
Inorganic Chemistry (2005) 44, 9175-9184
a=9.9218(7)Å b=13.1236(9)Å c=18.0166(16)Å
α=90.00° β=90.00° γ=90.00°
C61H81Cl4Co2N9O12S8
C61H81Cl4Co2N9O12S8
Inorganic Chemistry (2005) 44, 9175-9184
a=21.668(3)Å b=15.8946(15)Å c=13.8390(15)Å
α=90.00° β=113.520(4)° γ=90.00°
C70H94Br4Co2N14O12S8
C70H94Br4Co2N14O12S8
Inorganic Chemistry (2005) 44, 9175-9184
a=13.7222(8)Å b=15.4895(8)Å c=21.8774(14)Å
α=90.00° β=113.0740(10)° γ=90.00°
C14H16CuO8
C14H16CuO8
Crystal Growth & Design (2005) 5, 1 251
a=14.1063(9)Å b=7.6324(4)Å c=15.6342(10)Å
α=90.00° β=114.183(2)° γ=90.00°
C26H18CuN2O4
C26H18CuN2O4
Crystal Growth & Design (2005) 5, 1 251
a=22.073(2)Å b=15.3244(16)Å c=16.0220(16)Å
α=90.00° β=125.849(2)° γ=90.00°
C12H8Cu0.5NO2
C12H8Cu0.5NO2
Crystal Growth & Design (2005) 5, 1 251
a=20.194(2)Å b=9.5131(9)Å c=11.4251(12)Å
α=90.00° β=117.022(2)° γ=90.00°
Ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro -2,6-dimethyl-3,5-pyridinedicarboxylate formamide
C18H19Cl2NO4,CH3ON
Crystal Growth & Design (2009) 9, 3 1254
a=9.6360(19)Å b=11.335(2)Å c=11.685(2)Å
α=100.99(3)° β=112.09(3)° γ=107.52(3)°
Felodipine
C72H76Cl8N4O16
Crystal Growth & Design (2009) 9, 3 1254
a=32.392(7)Å b=18.717(4)Å c=23.711(5)Å
α=90.00° β=91.00(3)° γ=90.00°